EXACT SCIENCES CORP|4Mar 15, 4:37 PM ET

LIDGARD GRAHAM PETER 4

4 · EXACT SCIENCES CORP · Filed Mar 15, 2021

Form 4

Period: 2021-03-11

SVP, Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2021-03-11$21.68/sh+34,891$756,437→ 73,258 total
Exercise/Conversion
Common Stock
2021-03-11$44.37/sh+8,350$370,490→ 81,608 total
Sale
Common Stock
2021-03-11$130.00/sh−43,241$5,621,330→ 38,367 total
Exercise/Conversion
Stock Option (right to buy)
2021-03-11−34,891→ 0 total
Exercise: $21.68→ Common Stock (34,891 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-03-11−8,350→ 4,175 total
Exercise: $44.37→ Common Stock (8,350 underlying)

Holdings

Footnotes (5)

[F1]Represents shares of common stock received upon exercise of a stock option award.
[F2]The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan.
[F3]In addition to the shares of Common Stock reported on this Form 4, which total 55,886 shares, Mr. Lidgard also holds, in the aggregate, an additional 63,752 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
[F4]These options vested and became exercisable in four equal annual installments beginning on February 23, 2018.
[F5]These options vest and become exercisable in four equal annual installments beginning on February 27, 2019.

Documents

1 file